Ruhani Doda Khera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ruhani Doda Khera has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Fatemeh Homayounieh
Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
4 shared publications - Mannudeep K. Kalra
Department of Radiology, Massachusetts General Hospital, Boston, MA 02114, USA
4 shared publications - Bernardo Canedo Bizzo
Data Science Institute, Reston, VA, Senior Director, Mass General Brigham AI, Boston, MA
2 shared publications - Bernhard Schmidt
Siemens Healthcare GmbH, 91052 Erlangen, Germany
2 shared publications Ramandeep Singh
Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
2 shared publications- Sanjay Saini
Department of Radiology, Massachusetts General Hospital, Boston, MA 02114, USA
2 shared publications
Latest Publications
- 19 August 2022
- Published by Elsevier in Magnetic Resonance Imaging Clinics of North America
- Vol. 30 (3) , 553-563
ED MRI: Safety, Consent, and Regulatory Considerations
- 19 August 2022
- Published by Elsevier in Magnetic Resonance Imaging Clinics of North America
- Vol. 30 (3) , 553-563
ED MRI: Safety, Consent, and Regulatory Considerations
- 25 February 2021
- Published by Springer Nature in Journal of Digital Imaging
- Vol. 34 (2) , 320-329
Multicenter Assessment of CT Pneumonia Analysis Prototype for Predicting Disease Severity and Patient Outcome
To perform a multicenter assessment of the CT Pneumonia Analysis prototype for predicting disease severity and patient outcome in COVID-19 pneumonia both without and with integration of clinical information. Our IRB-approved observational study included consecutive 241 adult patients (> 18 years; 105 females; 136 males) with RT-PCR-positive COVID-19 pneumonia who underwent non-contrast chest CT at one of the two tertiary care hospitals (site A: Massachusetts General Hospital, USA; site B: Firoozgar Hospital Iran). We recorded patient age, gender, comorbid conditions, laboratory values, intensive care unit (ICU) admission, mechanical ventilation, and final outcome (recovery or death). Two thoracic radiologists reviewed all chest CTs to record type, extent of pulmonary opacities based on the percentage of lobe involved, and severity of respiratory motion artifacts. Thin-section CT images were processed with the prototype (Siemens Healthineers) to obtain quantitative features including lung volumes, volume and percentage of all-type and high-attenuation opacities (≥ −200 HU), and mean HU and standard deviation of opacities within a given lung region. These values are estimated for the total combined lung volume, and separately for each lung and each lung lobe. Multivariable analyses of variance (MANOVA) and multiple logistic regression were performed for data analyses. About 26% of chest CTs (62/241) had moderate to severe motion artifacts. There were no significant differences in the AUCs of quantitative features for predicting disease severity with and without motion artifacts (AUC 0.94–0.97) as well as for predicting patient outcome (AUC 0.7–0.77) (p > 0.5). Combination of the volume of all-attenuation opacities and the percentage of high-attenuation opacities (AUC 0.76–0.82, 95% confidence interval (CI) 0.73–0.82) had higher AUC for predicting ICU admission than the subjective severity scores (AUC 0.69–0.77, 95% CI 0.69–0.81). Despite a high frequency of motion artifacts, quantitative features of pulmonary opacities from chest CT can help differentiate patients with favorable and adverse outcomes.
- 25 February 2021
- Published by Springer Nature in Journal of Digital Imaging
- Vol. 34 (2) , 320-329
Multicenter Assessment of CT Pneumonia Analysis Prototype for Predicting Disease Severity and Patient Outcome
To perform a multicenter assessment of the CT Pneumonia Analysis prototype for predicting disease severity and patient outcome in COVID-19 pneumonia both without and with integration of clinical information. Our IRB-approved observational study included consecutive 241 adult patients (> 18 years; 105 females; 136 males) with RT-PCR-positive COVID-19 pneumonia who underwent non-contrast chest CT at one of the two tertiary care hospitals (site A: Massachusetts General Hospital, USA; site B: Firoozgar Hospital Iran). We recorded patient age, gender, comorbid conditions, laboratory values, intensive care unit (ICU) admission, mechanical ventilation, and final outcome (recovery or death). Two thoracic radiologists reviewed all chest CTs to record type, extent of pulmonary opacities based on the percentage of lobe involved, and severity of respiratory motion artifacts. Thin-section CT images were processed with the prototype (Siemens Healthineers) to obtain quantitative features including lung volumes, volume and percentage of all-type and high-attenuation opacities (≥ −200 HU), and mean HU and standard deviation of opacities within a given lung region. These values are estimated for the total combined lung volume, and separately for each lung and each lung lobe. Multivariable analyses of variance (MANOVA) and multiple logistic regression were performed for data analyses. About 26% of chest CTs (62/241) had moderate to severe motion artifacts. There were no significant differences in the AUCs of quantitative features for predicting disease severity with and without motion artifacts (AUC 0.94–0.97) as well as for predicting patient outcome (AUC 0.7–0.77) (p > 0.5). Combination of the volume of all-attenuation opacities and the percentage of high-attenuation opacities (AUC 0.76–0.82, 95% confidence interval (CI) 0.73–0.82) had higher AUC for predicting ICU admission than the subjective severity scores (AUC 0.69–0.77, 95% CI 0.69–0.81). Despite a high frequency of motion artifacts, quantitative features of pulmonary opacities from chest CT can help differentiate patients with favorable and adverse outcomes.
- 26 November 2020
- Published by Springer Nature in Abdominal Radiology
- Vol. 46 (5) , 2097-2106
Prediction of burden and management of renal calculi from whole kidney radiomics: a multicenter study
Purpose To assess if autosegmentation-assisted radiomics can predict disease burden, hydronephrosis, and treatment strategies in patients with renal calculi. Methods The local ethical committee-approved, retrospective study included 202 adult patients (mean age: 53 ± 17 years; male: 103; female: 99) who underwent clinically indicated, non-contrast abdomen-pelvis CT for suspected or known renal calculi. All CT examinations were reviewed to determine the presence (n = 123 patients) or absence (n = 79) of renal calculi. On CT images with renal calculi, each kidney stone was annotated and measured (maximum dimension, Hounsfield unit (HU), and combined and dominant stone volumes) using a HU threshold-based segmentation. We recorded the presence of hydronephrosis, number of renal calculi, and treatment strategies. Deidentified CT images were processed with the radiomics prototype (Radiomics, Frontier, Siemens Healthineers), which automatically segmented each kidney to obtain 1690 first-, shape-, and higher-order radiomics. Data were analyzed using multiple logistic regression analysis with areas under the curve (AUC) as output. Results Among 202 patients, only 28 patients (18%) needed procedural treatment (lithotripsy or ureteroscopic stone extraction). Gray-level co-occurrence matrix (GLCM) and gray-level run length matrix (GLRLM) differentiated patients with and without procedural treatment (AUC 0.91, 95% CI 0.85–0.92). Higher-order radiomics (gray-level size zone matrix – GLSZM) differentiated kidneys with and without hydronephrosis (AUC: 0.99, p < 0.001) as well those with different stone volumes (AUC up to 0.89, 95% CI 0.89–0.92). Conclusion Automated segmentation and radiomics of entire kidneys can assess hydronephrosis presence, stone burden, and treatment strategies for renal calculi with AUCs > 0.85.
- 26 November 2020
- Published by Springer Nature in Abdominal Radiology
- Vol. 46 (5) , 2097-2106
Prediction of burden and management of renal calculi from whole kidney radiomics: a multicenter study
Purpose To assess if autosegmentation-assisted radiomics can predict disease burden, hydronephrosis, and treatment strategies in patients with renal calculi. Methods The local ethical committee-approved, retrospective study included 202 adult patients (mean age: 53 ± 17 years; male: 103; female: 99) who underwent clinically indicated, non-contrast abdomen-pelvis CT for suspected or known renal calculi. All CT examinations were reviewed to determine the presence (n = 123 patients) or absence (n = 79) of renal calculi. On CT images with renal calculi, each kidney stone was annotated and measured (maximum dimension, Hounsfield unit (HU), and combined and dominant stone volumes) using a HU threshold-based segmentation. We recorded the presence of hydronephrosis, number of renal calculi, and treatment strategies. Deidentified CT images were processed with the radiomics prototype (Radiomics, Frontier, Siemens Healthineers), which automatically segmented each kidney to obtain 1690 first-, shape-, and higher-order radiomics. Data were analyzed using multiple logistic regression analysis with areas under the curve (AUC) as output. Results Among 202 patients, only 28 patients (18%) needed procedural treatment (lithotripsy or ureteroscopic stone extraction). Gray-level co-occurrence matrix (GLCM) and gray-level run length matrix (GLRLM) differentiated patients with and without procedural treatment (AUC 0.91, 95% CI 0.85–0.92). Higher-order radiomics (gray-level size zone matrix – GLSZM) differentiated kidneys with and without hydronephrosis (AUC: 0.99, p < 0.001) as well those with different stone volumes (AUC up to 0.89, 95% CI 0.89–0.92). Conclusion Automated segmentation and radiomics of entire kidneys can assess hydronephrosis presence, stone burden, and treatment strategies for renal calculi with AUCs > 0.85.
- 26 June 2020
- Published by Springer Nature in International Journal of Computer Assisted Radiology and Surgery
- Vol. 15 (10) , 1727-1736
Accuracy of radiomics for differentiating diffuse liver diseases on non-contrast CT
Purpose Radiomics help move cross-sectional imaging into the domain of quantitative imaging to assess the lesions, their stoma as well as in their temporal monitoring. We applied and assessed the accuracy of radiomics for differentiating healthy liver from diffuse liver diseases (cirrhosis, steatosis, amiodarone deposition, and iron overload) on non-contrast abdomen CT images in an institutional-reviewed board-approved, retrospective study. Methods Our study included 300 adult patients (mean age 63 ± 16 years; 171 men, 129 women) who underwent non-contrast abdomen CT and had either a healthy liver (n = 100 patients) or an evidence of diffuse liver disease (n = 200). The diffuse liver diseases included steatosis (n = 50), cirrhosis (n = 50), hyperdense liver due to amiodarone deposition (n = 50), or iron overload (n = 50). We manually segmented the liver in one section at the level of the porta hepatis (all 300 patients) and then over the entire liver volume (50 patients). Radiomics were estimated for the liver, and statistical comparison was performed with multiple logistic regression and random forest classifier. Results With random forest classifier, the AUC for radiomics ranged between 0.72 (iron overload vs. healthy liver) and 0.98 (hepatic steatosis vs. healthy liver) for differentiating diffuse liver disease from the healthy liver. Combined root mean square and gray-level co-occurrence matrix had the highest AUC (AUC:0.99, p < 0.01) for differentiating healthy liver from steatosis. Radiomics were more accurate for differentiating healthy liver from amiodarone (AUC:0.93) than from iron overload (AUC:0.79). Conclusion Radiomics enable differentiation of healthy liver from hepatic steatosis, cirrhosis, amiodarone deposition, and iron overload from a single section of non-contrast abdominal CT. The high accuracy of radiomics coupled with rapid segmentation of the region of interest, radiomics estimation, and statistical analyses within the same prototype makes a compelling case for bringing radiomics to clinical use for improving reporting in evaluation of healthy liver and diffuse liver diseases.
- 26 June 2020
- Published by Springer Nature in International Journal of Computer Assisted Radiology and Surgery
- Vol. 15 (10) , 1727-1736
Accuracy of radiomics for differentiating diffuse liver diseases on non-contrast CT
Purpose Radiomics help move cross-sectional imaging into the domain of quantitative imaging to assess the lesions, their stoma as well as in their temporal monitoring. We applied and assessed the accuracy of radiomics for differentiating healthy liver from diffuse liver diseases (cirrhosis, steatosis, amiodarone deposition, and iron overload) on non-contrast abdomen CT images in an institutional-reviewed board-approved, retrospective study. Methods Our study included 300 adult patients (mean age 63 ± 16 years; 171 men, 129 women) who underwent non-contrast abdomen CT and had either a healthy liver (n = 100 patients) or an evidence of diffuse liver disease (n = 200). The diffuse liver diseases included steatosis (n = 50), cirrhosis (n = 50), hyperdense liver due to amiodarone deposition (n = 50), or iron overload (n = 50). We manually segmented the liver in one section at the level of the porta hepatis (all 300 patients) and then over the entire liver volume (50 patients). Radiomics were estimated for the liver, and statistical comparison was performed with multiple logistic regression and random forest classifier. Results With random forest classifier, the AUC for radiomics ranged between 0.72 (iron overload vs. healthy liver) and 0.98 (hepatic steatosis vs. healthy liver) for differentiating diffuse liver disease from the healthy liver. Combined root mean square and gray-level co-occurrence matrix had the highest AUC (AUC:0.99, p < 0.01) for differentiating healthy liver from steatosis. Radiomics were more accurate for differentiating healthy liver from amiodarone (AUC:0.93) than from iron overload (AUC:0.79). Conclusion Radiomics enable differentiation of healthy liver from hepatic steatosis, cirrhosis, amiodarone deposition, and iron overload from a single section of non-contrast abdominal CT. The high accuracy of radiomics coupled with rapid segmentation of the region of interest, radiomics estimation, and statistical analyses within the same prototype makes a compelling case for bringing radiomics to clinical use for improving reporting in evaluation of healthy liver and diffuse liver diseases.
- 4 May 2020
- Published by SAGE Publications in Canadian Association of Radiologists Journal
- Vol. 72 (3) , 505-511
Multiplatform, Non-Breath-Hold Fast Scanning Protocols: Should We Stop Giving Breath-Hold Instructions for Routine Chest CT?
Objective: We assessed if non-breath-hold (NBH) fast scanning protocol can provide respiratory motion-free images for interpretation of chest computed tomography (CT). Materials and Methods: In our 2-phase project, we first collected baseline data on frequency of respiratory motion artifacts on breath-hold chest CT in 826 adult patients. The second phase included 62 patients (mean age 66 ± 15 years; 21 females, 41 males) who underwent an NBH chest CT on either single-source (n = 32) or dual-source (n = 30) multidetector-row CT scanners. Clinical indications for chest CT, reason for using NBH CT, scanner type, scan duration, and radiation dose (CT dose index volume, dose length product) were recorded. Two thoracic radiologists (R1 and R2) independently graded respiratory motion artifacts (1 = no respiratory motion artifacts with unrestricted evaluation; 2 = minor motion artifacts limited to one lung lobe or less with good diagnostic quality; 3 = moderate motion artifacts limited to 2 to 3 lung lobes but adequate for clinical diagnosis; 4 = poor evaluability or unevaluable from severe motion artifacts; and 5 = limited quality due to other causes like high noise, beam hardening, or metallic artifacts), and recorded pulmonary and mediastinal findings. Descriptive analyses, Cohen κ test for interobserver agreement, and Student t test were performed for statistical analysis. Results: No NBH chest CT were deemed uninterpretable by either radiologist; most NBH CT (R1-59 of 62, 95%; R2-62 of 62, 100%) had no or minimal motion artifacts. Only 3 of 62 (R1) NBH chest CT had motion artifacts limiting diagnostic evaluation for lungs but not in the mediastinum. Conclusion: Non-breath-hold fast protocol enables acquisition of diagnostic quality chest CT free of respiratory motion artifacts in patients who cannot hold their breath.
- 4 May 2020
- Published by SAGE Publications in Canadian Association of Radiologists Journal
- Vol. 72 (3) , 505-511
Multiplatform, Non-Breath-Hold Fast Scanning Protocols: Should We Stop Giving Breath-Hold Instructions for Routine Chest CT?
Objective: We assessed if non-breath-hold (NBH) fast scanning protocol can provide respiratory motion-free images for interpretation of chest computed tomography (CT). Materials and Methods: In our 2-phase project, we first collected baseline data on frequency of respiratory motion artifacts on breath-hold chest CT in 826 adult patients. The second phase included 62 patients (mean age 66 ± 15 years; 21 females, 41 males) who underwent an NBH chest CT on either single-source (n = 32) or dual-source (n = 30) multidetector-row CT scanners. Clinical indications for chest CT, reason for using NBH CT, scanner type, scan duration, and radiation dose (CT dose index volume, dose length product) were recorded. Two thoracic radiologists (R1 and R2) independently graded respiratory motion artifacts (1 = no respiratory motion artifacts with unrestricted evaluation; 2 = minor motion artifacts limited to one lung lobe or less with good diagnostic quality; 3 = moderate motion artifacts limited to 2 to 3 lung lobes but adequate for clinical diagnosis; 4 = poor evaluability or unevaluable from severe motion artifacts; and 5 = limited quality due to other causes like high noise, beam hardening, or metallic artifacts), and recorded pulmonary and mediastinal findings. Descriptive analyses, Cohen κ test for interobserver agreement, and Student t test were performed for statistical analysis. Results: No NBH chest CT were deemed uninterpretable by either radiologist; most NBH CT (R1-59 of 62, 95%; R2-62 of 62, 100%) had no or minimal motion artifacts. Only 3 of 62 (R1) NBH chest CT had motion artifacts limiting diagnostic evaluation for lungs but not in the mediastinum. Conclusion: Non-breath-hold fast protocol enables acquisition of diagnostic quality chest CT free of respiratory motion artifacts in patients who cannot hold their breath.
- Open Access
- 14 August 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-7
Deploying Clinical Process Improvement Strategies to Reduce Motion Artifacts and Expiratory Phase Scanning in Chest CT
We hypothesized that clinical process improvement strategies can reduce frequency of motion artifacts and expiratory phase scanning in chest CT. We reviewed 826 chest CT to establish the baseline frequency. Per clinical process improvement guidelines, we brainstormed corrective measures and priority-pay-off matrix. The first intervention involved education of CT technologists, following which 795 chest CT were reviewed. For the second intervention, instructional videos on optimal breath-hold were shown to 245 adult patients just before their chest CT. Presence of motion artifacts and expiratory phase scanning was assessed. We also reviewed 311 chest CT scans belonging to a control group of patients who did not see the instructional videos. Pareto and percentage run charts were created for baseline and post-intervention data. Baseline incidence of motion artifacts and expiratory phase scanning in chest CT was 35% (292/826). There was no change in the corresponding incidence following the first intervention (36%; 283/795). Respiratory motion and expiratory phase chest CT with the second intervention decreased (8%, 20/245 patients). Instructional videos for patients (and not education and training of CT technologists) reduce the frequency of motion artifacts and expiratory phase scanning in chest CT.
- 14 August 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-7
Open AccessDeploying Clinical Process Improvement Strategies to Reduce Motion Artifacts and Expiratory Phase Scanning in Chest CT
We hypothesized that clinical process improvement strategies can reduce frequency of motion artifacts and expiratory phase scanning in chest CT. We reviewed 826 chest CT to establish the baseline frequency. Per clinical process improvement guidelines, we brainstormed corrective measures and priority-pay-off matrix. The first intervention involved education of CT technologists, following which 795 chest CT were reviewed. For the second intervention, instructional videos on optimal breath-hold were shown to 245 adult patients just before their chest CT. Presence of motion artifacts and expiratory phase scanning was assessed. We also reviewed 311 chest CT scans belonging to a control group of patients who did not see the instructional videos. Pareto and percentage run charts were created for baseline and post-intervention data. Baseline incidence of motion artifacts and expiratory phase scanning in chest CT was 35% (292/826). There was no change in the corresponding incidence following the first intervention (36%; 283/795). Respiratory motion and expiratory phase chest CT with the second intervention decreased (8%, 20/245 patients). Instructional videos for patients (and not education and training of CT technologists) reduce the frequency of motion artifacts and expiratory phase scanning in chest CT.